Sequencing Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 31

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 13

Sequencing General Information

Description

Developer of a deoxyribonucleic acid testing and analysis platform designed to provide personalized health care tailored to an individual's genome. The company's platform allows users to upload DNA data online and get full access to analysis, reports, and insights about their ancestry, improving health and screening for rare diseases such as cancer prevention, enabling patients to avoid medication reactions and optimize their nutrition.

Contact Information

Website
www.sequencing.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 680 East Colorado Boulevard
  • Suite 180
  • Pasadena, CA 91101
  • United States
+1 (833)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 680 East Colorado Boulevard
  • Suite 180
  • Pasadena, CA 91101
  • United States
+1 (833)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sequencing Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 07-Nov-2022 Cancelled Generating Revenue
2. Seed Round 07-Nov-2022 Completed Generating Revenue
1. Seed Round 01-May-2021 Completed Startup
To view Sequencing’s complete valuation and funding history, request access »

Sequencing Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-5
Seed-4
Seed-3
Seed-2 3,631,725 $0.000100 $0.27 $0.27 1x $0.27 21.67%
Seed-1 3,692,216 $0.000100 $1.35 $1.35 1x $1.35 22.03%
To view Sequencing’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sequencing Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a deoxyribonucleic acid testing and analysis platform designed to provide personalized health care tailored
Diagnostic Equipment
Pasadena, CA
31 As of 2025

Lausanne, Switzerland
 

Bicester, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sequencing Competitors (22)

One of Sequencing’s 22 competitors is Abionic, a Venture Capital-Backed company based in Lausanne, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Abionic Venture Capital-Backed Lausanne, Switzerland
FitnessGenes Venture Capital-Backed Bicester, United Kingdom
WellnessFX Formerly VC-backed San Francisco, CA
New Amsterdam Genomics Corporation Cambridge, MA
Mindera Health Venture Capital-Backed Vista, CA
You’re viewing 5 of 22 competitors. Get the full list »

Sequencing Patents

  • 6

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Sequencing Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160321395-A1 System and method for real-time personalization utilizing an individual's genomic data Inactive 07-Dec-2013
EP-3077942-A4 System and method for real-time personalization utilizing an individual's genomic data Inactive 07-Dec-2013
CA-2932914-A1 System and method for real-time personalization utilizing an individual's genomic data Inactive 07-Dec-2013
AU-2014360079-A1 System and method for real-time personalization utilizing an individual's genomic data Inactive 07-Dec-2013
EP-3077942-A1 System and method for real-time personalization utilizing an individual's genomic data Inactive 07-Dec-2013 G16B20/20
To view Sequencing’s complete patent history, request access »

Sequencing Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sequencing Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
BlueLotus Ventures Venture Capital Minority
Correlation Ventures Venture Capital Minority
Expansion Venture Capital Venture Capital Minority
Gaingels Venture Capital Minority
Hemisphere Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

Sequencing FAQs

  • When was Sequencing founded?

    Sequencing was founded in 2014.

  • Where is Sequencing headquartered?

    Sequencing is headquartered in Pasadena, CA.

  • What is the size of Sequencing?

    Sequencing has 31 total employees.

  • What industry is Sequencing in?

    Sequencing’s primary industry is Diagnostic Equipment.

  • Is Sequencing a private or public company?

    Sequencing is a Private company.

  • What is Sequencing’s current revenue?

    The current revenue for Sequencing is .

  • How much funding has Sequencing raised over time?

    Sequencing has raised $8M.

  • Who are Sequencing’s investors?

    BlueLotus Ventures, Correlation Ventures, Expansion Venture Capital, Gaingels, and Hemisphere Ventures are 5 of 13 investors who have invested in Sequencing.

  • Who are Sequencing’s competitors?

    Abionic, FitnessGenes, WellnessFX, New Amsterdam Genomics, and Mindera Health are some of the 22 competitors of Sequencing.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »